A detailed history of 1492 Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, 1492 Capital Management LLC holds 161,055 shares of VRNA stock, worth $5.74 Million. This represents 2.51% of its overall portfolio holdings.

Number of Shares
161,055
Previous 163,647 1.58%
Holding current value
$5.74 Million
Previous $2.37 Million 95.82%
% of portfolio
2.51%
Previous 1.44%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.46 - $30.16 $40,072 - $78,174
-2,592 Reduced 1.58%
161,055 $4.63 Million
Q2 2024

Aug 13, 2024

SELL
$11.48 - $17.02 $7,071 - $10,484
-616 Reduced 0.38%
163,647 $2.37 Million
Q1 2024

May 13, 2024

SELL
$15.3 - $20.24 $27,157 - $35,926
-1,775 Reduced 1.07%
164,263 $2.64 Million
Q4 2023

Feb 12, 2024

BUY
$11.94 - $20.47 $18,853 - $32,322
1,579 Added 0.96%
166,038 $3.3 Million
Q3 2023

Nov 13, 2023

BUY
$16.3 - $22.09 $379,154 - $513,835
23,261 Added 16.47%
164,459 $2.68 Million
Q2 2023

Aug 11, 2023

BUY
$19.41 - $23.43 $1.46 Million - $1.77 Million
75,359 Added 114.46%
141,198 $2.98 Million
Q1 2023

May 12, 2023

SELL
$18.06 - $25.27 $415 - $581
-23 Reduced 0.03%
65,839 $1.32 Million
Q3 2022

Nov 10, 2022

BUY
$4.14 - $13.59 $272,668 - $895,064
65,862 New
65,862 $673,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.